Clinical Trial Update: Ameliorating Contrast Induced Nephropathy After Coronary Angiography [Phase 4]

View source ↗

Summary

Phase 4 clinical trial from Ain Shams University evaluating methods to prevent contrast-induced nephropathy after coronary angiography; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Coronary Artery Disease

Snippet

Sponsor: Ain Shams University | Conditions: Coronary Artery Disease, Nephropathy; Toxic, Drugs | Phase 4 | Status: COMPLETED